Repligen posted solid growth and beat Wall Street's sales and adjusted earnings estimates.

Equity analysts in Manhattan have a difficult time imagining the logistics needs in Brazil. In this podcast, Motley Fool ...

Moving forward, Shift4 Payments has raised its guidance for key financial metrics, including its gross revenue less network ...

Axsome Therapeutics surpassed revenue expectations in Q3, driven by strong sales from its key products.

Total revenue for Q3 was $13.5 million, missing the $16.2 million analyst estimate. Operating expenses dropped by 24%, ...

Billionaire hedge fund managers and Wall Street analysts agree this ETF and similar investments are set to soar over the next ...

Arm Holdings ( ARM 0.04%) has been one of the biggest winners in the artificial intelligence (AI) boom. The company was late ...

Jefferies analyst Greg Konrad downgraded AeroVironment stock from buy to hold today. Shares of the military drone maker have ...

The IT services specialist delivered stable revenue growth in its fiscal 2025 first quarter, but profits sank.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Many or all of the products here are from our partners that compensate us. It’s how we make money. But our editorial ...

Cronos Group ( CRON 10.60%) Q3 2024 Earnings Call Nov 12, 2024, 8:30 a.m. ET Good morning. My name is Brianna, and I will be ...